DD266801A5 - Verfahren zur herstellung einer oestrogen wirksamen verbindung - Google Patents

Verfahren zur herstellung einer oestrogen wirksamen verbindung Download PDF

Info

Publication number
DD266801A5
DD266801A5 DD87305964A DD30596487A DD266801A5 DD 266801 A5 DD266801 A5 DD 266801A5 DD 87305964 A DD87305964 A DD 87305964A DD 30596487 A DD30596487 A DD 30596487A DD 266801 A5 DD266801 A5 DD 266801A5
Authority
DD
German Democratic Republic
Prior art keywords
estra
ethano
hydrogen atom
group
methyl
Prior art date
Application number
DD87305964A
Other languages
German (de)
English (en)
Inventor
James R Bull
Russel I Thomson
Henry Laurent
Helmut Schroeder
Rudolf Wiechert
Original Assignee
�����������@�������������@����������@��@������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �����������@�������������@����������@��@������k�� filed Critical �����������@�������������@����������@��@������k��
Publication of DD266801A5 publication Critical patent/DD266801A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DD87305964A 1986-08-20 1987-08-12 Verfahren zur herstellung einer oestrogen wirksamen verbindung DD266801A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863628189 DE3628189A1 (de) 1986-08-20 1986-08-20 Oestrogen wirksame mittel und 14,17ss-ethano-14ss-estratriene

Publications (1)

Publication Number Publication Date
DD266801A5 true DD266801A5 (de) 1989-04-12

Family

ID=6307762

Family Applications (1)

Application Number Title Priority Date Filing Date
DD87305964A DD266801A5 (de) 1986-08-20 1987-08-12 Verfahren zur herstellung einer oestrogen wirksamen verbindung

Country Status (22)

Country Link
US (1) US4789671A (no)
EP (1) EP0318490B1 (no)
JP (1) JPH02500739A (no)
KR (1) KR940000167B1 (no)
CN (1) CN1027270C (no)
AT (1) ATE72248T1 (no)
AU (1) AU618939B2 (no)
CA (1) CA1269102A (no)
DD (1) DD266801A5 (no)
DE (2) DE3628189A1 (no)
DK (1) DK186788A (no)
FI (1) FI94866C (no)
HU (1) HU203366B (no)
IE (1) IE60319B1 (no)
IL (1) IL83302A (no)
NO (2) NO167865C (no)
NZ (1) NZ221137A (no)
PT (1) PT85552B (no)
RU (1) RU1820910C (no)
UA (1) UA13378A (no)
WO (1) WO1988001275A1 (no)
ZA (1) ZA875359B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3838779A1 (de) * 1988-11-11 1990-05-17 Schering Ag 14(alpha),17(alpha)-ethano-estratriene
DE3925507A1 (de) * 1989-07-28 1991-01-31 Schering Ag 14,17(alpha)-etheno- und ethanoestratriene, verfahren zur herstellung dieser verbindungen, sowie ihre verwendung zur herstellung von arzneimitteln
RU2087479C1 (ru) * 1989-11-29 1997-08-20 Шеринг Аг Эстратриены, содержащие мостик
DE4114634A1 (de) * 1991-04-30 1992-11-05 Schering Ag 14(alpha),17(alpha)-(propano- und 17(pfeil hoch)2(pfeil hoch)-propeno)estratriene
DE4114635A1 (de) * 1991-04-30 1992-11-05 Schering Ag 14(alpha),16(alpha)-ethano-estratriene
DE4222316A1 (de) * 1992-07-03 1994-01-05 Schering Ag Verfahren zur Herstellung von Etheno- und Ethano-16â,17µ-Steroiddiolen und deren Derivaten
DE4326240A1 (de) * 1993-08-02 1995-02-09 Schering Ag 15,15-Dialkyl-substituierte Derivate des Estradiols
DE4447401A1 (de) 1994-12-23 1996-07-04 Schering Ag 14,17-C¶2¶-überbrückte Steroide
US7435757B2 (en) * 2004-07-02 2008-10-14 Schering Ag 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1

Also Published As

Publication number Publication date
FI890779A (fi) 1989-02-17
AU7757187A (en) 1988-03-08
HUT50845A (en) 1990-03-28
JPH0515720B2 (no) 1993-03-02
DE3628189A1 (de) 1988-02-25
NO885112L (no) 1988-04-19
NO168481C (no) 1992-04-01
FI94866B (fi) 1995-07-31
WO1988001275A1 (en) 1988-02-25
ATE72248T1 (de) 1992-02-15
JPH02500739A (ja) 1990-03-15
AU618939B2 (en) 1992-01-16
NO167865B (no) 1991-09-09
IL83302A0 (en) 1987-12-31
NO168481B (no) 1991-11-18
DK186788D0 (da) 1988-04-06
PT85552A (en) 1987-09-01
KR880701731A (ko) 1988-11-04
PT85552B (pt) 1990-05-31
EP0318490B1 (de) 1992-01-29
IL83302A (en) 1991-09-16
FI94866C (fi) 1995-11-10
US4789671A (en) 1988-12-06
DK186788A (da) 1988-04-06
HU203366B (en) 1991-07-29
NO881688L (no) 1988-04-19
FI890779A0 (fi) 1989-02-17
DE3776572D1 (de) 1992-03-12
NO167865C (no) 1991-12-18
CN1027270C (zh) 1995-01-04
RU1820910C (ru) 1993-06-07
NO881688D0 (no) 1988-04-19
NO885112D0 (no) 1988-11-16
UA13378A (uk) 1997-02-28
KR940000167B1 (ko) 1994-01-08
NZ221137A (en) 1990-09-26
IE872217L (en) 1988-02-20
EP0318490A1 (de) 1989-06-07
ZA875359B (en) 1988-02-05
CN87105736A (zh) 1988-03-09
CA1269102A (en) 1990-05-15
IE60319B1 (en) 1994-06-29

Similar Documents

Publication Publication Date Title
DE2805490A1 (de) In 11beta-stellung substituierte steroide der oestranreihe
DD266801A5 (de) Verfahren zur herstellung einer oestrogen wirksamen verbindung
DE3838779A1 (de) 14(alpha),17(alpha)-ethano-estratriene
DE3741801A1 (de) 17-methylen-estratriene
CH618182A5 (no)
EP0430386B1 (de) 14Alpha, 17alpha-überbrückte 16-Hydroxyestratriene
DE4326240A1 (de) 15,15-Dialkyl-substituierte Derivate des Estradiols
EP0034114B1 (de) 3-Desoxy-delta-15-Steroide, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate
EP0017094B1 (de) 11-Methylensteroide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE2207421C3 (de) 15α, 16α -Methylen-4-östren-17β -ole bzw. -acylate, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
EP0092173B1 (de) 11Beta-Chlor-Steroide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE2651364A1 (de) Neue d-homosteroide
EP0513947B1 (de) 14Alpha,16alpha-Ethano- und 14alpha,16alpha-Ethenoestratriene
DE1493165C3 (de) 1 -Hydroxyöstradiol-Derivate, Verfahren zu ihrer Herstellung sowie diese enthaltendes Mittel
DD209636A5 (de) Verfahren zur herstellung von 11beta-chlor-delta-hoch 15-steroiden
EP0511727B1 (de) 14Alpha,17alpha-(Propano- und 17,2-Propeno)-estratriene
DE2056512C3 (no)
DE1493092C (de) Gonatnen Derivate und Verfahren zu ihrer Herstellung
DE1493093C3 (no)
DE3939893A1 (de) 14(alpha),17(alpha)-etha(e)no-16ss-hydroxy-estratriene
DE1593509A1 (de) 1-Hydroxy-7alpha-methyl-oestradiol-Derivate
DE2755578A1 (de) C-homo-oestratriene
WO1993025569A1 (de) Estradiol-prodrugs
DE3939894A1 (de) 14(alpha),17(alpha)-ethano-16(alpha)-hydroxy-estratriene
DE1618712A1 (de) Verfahren zur Herstellung von 16-Methylen-19-nor-4-pregnan-derivaten

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee